课题基金 / 基金详情

Mechanisms of chemopreventive effect of resveratrol

Mechanisms of chemopreventive effect of resveratrol
白藜芦醇的化学预防作用机制
批准号:
6965805
负责人:
Zigang Dong
金额:
$29.82万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-06-30 至 2010-05-31

项目摘要

项目成果

Zigang Dong的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Resveratrol has shown a strong chemopreventive effect against cancer. However, the molecular mechanisms by which resveratrol inhibits carcinogenesis are not clear. We will use COX-2 gene knockout mice and JB6, HaCaT and other cell culture systems to examine the anti-tumor promotion effect of resveratrol at the molecular level. Our hypothesis is that the inhibition of skin carcinogenesis by resveratrol occurs through an inhibition of COX-2 activity and induction of cell apoptosis. The specific aims to address the hypothesis are as follows: Specific Aim 1. To investigate whether the anti-skin carcinogenesis activity of resveratrol occurs through the COX-2 pathway by using the COX-2+/+ and COX-2-/ mouse model. Specific Aim 2. To investigate the role of COX-2 in resveratrol-induced cell death (apoptosis). Specific Aim 3. To determine the structure/activity relationship of resveratrol and its derivatives on cell transformation, apoptosis and phosphatidylinositol-3 (PI-3) kinases. We have established experimental conditions, including COX-2 knockout mice and cell lines, arid synthesis of resveratrol derivatives, in our preliminary studies. Our long-term goal is to identify the molecular mechanism explaining the anti-tumor effect exhibited by resveratrol. Such knowledge will help in developing better chemopreventive agents with fewer side effects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chemoprevention of colon cancer by targeting the Wnt/beta-catenin pathway
  • 批准号:
    9035378
  • 项目类别:
  • 资助金额:
    $34.88万
  • 财政年份:
    2015
  • 负责人:
    Zigang Dong
  • 依托单位:
Prevention of solar UV-induced skin cancer by targeting LTA4H
  • 批准号:
    9301501
  • 项目类别:
  • 资助金额:
    $34.88万
  • 财政年份:
    2015
  • 负责人:
    Zigang Dong
  • 依托单位:
Chemoprevention of colon cancer by targeting the Wnt/beta-catenin pathway
  • 批准号:
    9249395
  • 项目类别:
  • 资助金额:
    $34.88万
  • 财政年份:
    2015
  • 负责人:
    Zigang Dong
  • 依托单位:
Prevention of solar UV-induced skin cancer by targeting LTA4H
  • 批准号:
    9114539
  • 项目类别:
  • 资助金额:
    $34.88万
  • 财政年份:
    2015
  • 负责人:
    Zigang Dong
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
  • 批准号:
    31970691
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2019
  • 负责人:
    张胜萍
  • 依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
  • 批准号:
    31900527
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2019
  • 负责人:
    孙磊
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位: